Chinese Journal of Clinical Oncology

, Volume 1, Issue 6, pp 448–453 | Cite as

Effects of125I-labeled peptide nuclear acid targeting Ki67 on the growth of implanted human renal cell carcinoma in nude mice

  • Jiacun Chen
  • Junnian Zheng
  • Song Wu
  • Haibiao Lai
  • Xiaoqing Sun
  • Junjie Liu
Original Articles



To investigate the potential of125I-labeled anti-sense peptide nucleic acids (125I-AS-PNAs) to inhibit the expression of the Ki-67 gene and growth of implanted human renal carcinoma cells in nude mice.


Anti-sense peptide nucleic acids (AS-PNAs) targeting the Ki67 gene were synthesized and labeled with125I by the Chloraseptine-T method. Drugs including PNAs and125I-AS-PNAs capsulated by cationic lipid were directly injected into tumors in nude mice. The Ki67 expression in tumors was detected by an immunohistochemical technique and Western blot. The apoptosis of tumor cells was detected by a TUNEL assay. Tumor volumes were measured every 3 days and tumor suppression rates were calculated at 12 days after treatment. Control groups were treated with AS-PNA, MM-PNAs (mismatch PNAs) and125l-Na.


The Ki67 expression rate of tumors treated by125I-AS-PNAs [( 15.3±1.8)%] was lower than that treated by AS-PNAs [(23.0±2.4)%] (P< 0.01). The Ki67 protein production rate of tumors treated by125I-AS-PNAs [(43.6±3.5)%] was lower than that treated by AS-PNAs [(59.7±2.3)%] (P< 0.01). The apoptosis rate of tumors treated by125I-AS-PNAs [(40.3±2.4)%] was higher than that treated by AS-PNAs [(31.1 ±2.0)%] (P< 0.01). The volume of tumors treated by125l-AS-PNAs [(330.4±57.8) mm3 ]was smaller than that treated by AS-PNAs[(513.2±64.2)mm3] (P< 0.01).


125I-AS-PNAs targeted against the Ki67 gene have a greater inhibitory effect on the expression of the Ki67 gene and a larger apoptotic action on human renal carcinoma cells and can more efficiently inhibit tumor growth than AS-PNAs.125I-AS-PNAs targeting the Ki67 gene may be a promising anti-sense/anti-gene radiotherapy method for treating renal cell carcinoma.


peptide nucleic acids Ki67 gene gene radiotherapy radionuclide renal cell carcinoma apoptosis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nielsen PE, Egholm M, Berg RH, et al. Sequence-selective recognition of DNA by strand displacement with a Thymine-substituted polyamide. Science. 1991 ;254:1497–1500.PubMedCrossRefGoogle Scholar
  2. 2.
    Norton JC, Piatyszek MA, Wright WE, et al. Inhibition of human telomerase acitivity by peptide nucleic acids. Nat Biotechnol. 1996;14:710–716.CrossRefGoogle Scholar
  3. 3.
    Zheng JN, Sun XQ, Chen JC, et al. Effects of125I-labeled Ki67 gene targeting peptide nucleic acids on the proliferation and apoptosis of human renal carcinoma cell line. Chin J Nuclear Med. 2004;24:139–141.Google Scholar
  4. 4.
    Endl E, Gerdes J. Posttranslational modifications of the Ki67 protein coincide with two major checkpoints during mitosis. J Cell Physiol. 2000;182:371–380.PubMedCrossRefGoogle Scholar
  5. 5.
    Nielsen PE, Egholm M. Srand displacement recognition of mixed adenine cytosine sequences in double stranded DNA by thymine-guanine PNA (peptide nucleic acid). Bioorg Med Chem. 2001;9:2429–2434.PubMedCrossRefGoogle Scholar
  6. 6.
    Jesen KK, Orum H, Nielsen PE, et al. Kinetics for hybridization of peptide nucleic acids (PNA) with DNA and RNA studied with BIAcore technique. Biochemistry. 1997; 36:5072–5077.CrossRefGoogle Scholar
  7. 7.
    Norton JC, Piatyszek MA, Wright WE, et al. Inhibition of human telomerase acitivity by peptide nucleic acids. Nat Biotechnol. 1996; 14:710–716.CrossRefGoogle Scholar
  8. 8.
    Panyutin IG, Neumann RD. Gene radiotherapy; gene targeted versus targeted by gene product. J Nucl Med. 1998; 39:928–929.PubMedGoogle Scholar
  9. 9.
    Gaidamakova EK, Neumann RD, Panyutin IG. Site-specific strand breaks in RNA produced by125I radiodecay. Nucleic Acids Res. 2002;30:4960–4965.PubMedCrossRefGoogle Scholar
  10. 10.
    Sedelnikova OA, Luu AN, Karamychev VN, et al. Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for antigene radiotherapy. Int J Radiat Oncol Biol Phys. 2001 ;49:391–396.PubMedCrossRefGoogle Scholar
  11. 11.
    Uhlmann E, Peyman A, Breipohl G, et al. PNA: synthetic polyamide nucleic acids with unusual binding properties. Angew Chem Int Ed Engl. 1998;37:2796–2823.CrossRefGoogle Scholar
  12. 12.
    Ray A, Norden B. Peptide nucleic acid (PNA): its medical and biotechnological applications and promise for the future. FASEB J. 2000;14:1041–1060.PubMedGoogle Scholar
  13. 13.
    Sauhney N, Hall PA. Ki67-structure, function, and new antibodies. J Path. 1992; 168:161–162.CrossRefGoogle Scholar
  14. 14.
    Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol. 1984;133: 1710–1715.PubMedGoogle Scholar

Copyright information

© Chinese Anti-Cancer Association and Springer 2004

Authors and Affiliations

  • Jiacun Chen
    • 1
  • Junnian Zheng
    • 1
  • Song Wu
    • 2
  • Haibiao Lai
    • 2
  • Xiaoqing Sun
    • 1
  • Junjie Liu
    • 1
  1. 1.Department of UrologyAffiliated Hospital of Xuzhou Medical CollegeXuzhouChina
  2. 2.Department of UrologyZhongshan Hospital of Traditional Chinese MedicineZhongshanChina

Personalised recommendations